Nalu Bio
Unlocking the endocannabinoid system (ECS) for healthier living
United States · $12.0M raised
- Business Model
- B2B
- Website
- nalubio.com
- Total Funding
- $12.0M
- Last Round
- $12.0M Series AFeb 2023
- Rounds
- 1
About
AI-powered drug discovery company focused on the endocannabinoid system.
Summary
Nalu Bio is an Artificial Intelligence company based in United States. It has raised $12.0M in total across 1 round, most recently a $12.0M Series A round in Feb 2023. Investors include Intrinsic Capital Partners, Flybridge Capital and Portfolia.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2023
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...